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Abstract 
Salivary gland choristoma (SGCh) is defined as the presence of normal salivary tissue in an abnormal location. It 
is a rare entity in oral and maxillofacial region and its ethiology is unknown. The typical presentation of salivary 
gland heterotopia is an asymptomatic mass that may or may not produce saliva. Some examples of ectopic salivary 
tissue in the pituitary gland, in the lymph nodes, in the middle ear, in the neck, in the jaw, in the thyroid gland, in 
the mediastinum and in the rectum have been documented in literature.
We report the case of a 61-year-old male presented with a bilateral tumorlike mass in the cheek. The mass was 
painless, of fibrous consistency and had size change with time. The histological diagnosis was salivary gland cho-
ristoma in the buccinator muscle. In this article, we will revise the characteristic of salivary gland heterotopias and 
we present a report case that has not been described in literature: a bilateral choristoma of salivary gland in the 
buccinator muscle, which should be included in the differential diagnosis of head and neck masses.
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Introduction
Salivary gland choristoma (SGCh) is defined as the pre-
sence of normal salivary tissue that appears in an ecto-
pic location. It is also denominated as aberrant salival 
tissue, salival heterotopia and ectopic salival tissue (1). 
It is different from hamartoma because the latter appears 
in normal location. 
SGCh has been documented in several areas of the body 
but rarely in the orofacial region (1,2). The most com-
mon locations are the posterior lobe of pituitary gland, 
the periparotid lymph nodes, the middle ear and the 
lower neck. Less common areas include upper neck, 
lingual mandible, external auditory canal, thyroid gland, 
mediastinum, prostate gland, vulva and rectum (3).
Several different heterotopias as osseous choristoma, 
cartilaginous choristoma, gastric mucosal choristoma, 
glial choristoma and thyroid choristoma have been des-
cribed in oral and maxillofacial region (4).
The etiopathogenesis of this entity remains uncertain 
although it is believed that it is due to a developmen-
tal anomaly (5). Sex and age predilection have not been 
described and the most typical clinical presentation, 
although it depends from choristoma location, is an as-
ymptomatic mass. However, SGCh can segregate saliva 
when stimulated (6).
The present case is the first described in the literature of 
a salivary gland choristoma in the buccinator muscle.
Report of Case 
A 61-year-old man was referred to the Unit of Oral Sur-
gery of the University of Barcelona in January of 2010 
presenting a bilateral tumefaction in the genian region. 
The patient had a chronic gastritis and reflux gastritis 
treated by metoclopramide since 1990 and a C-reactive 
protein level increase in his last blood analysis. He had 
seen treated of a depression since 1995. He didn’t have 
either allergies or toxic habits. He had undergone amig-
dalectomy (1967) and appendicectomy (1972).
The patient had a bilateral mass in both cheeks, roun-
ded, 1.5 cm of diameter, painless, of fibrous consisten-
cy, adhering to deep structures, without erythema and 
with a reported evolution of 2 years. The most striking 
clinical feature was sporadic swelling, associated so-
metimes with food intake. The swelling developed in 
5-7 days and remained from 15 days to some months. 
The patient visited an Oral and Maxillofacial Surgery 
service a year ago and was treated with antihistaminics 
and muscular relaxants that were unsuccessful to solve 
his complain.
A magnetic resonance of middle and lower face with 
axial planes was informed as unspecific pathology of the 
buccinator muscle (Fig. 1).
An incisional biopsy was perfomed with local anesthesia 
and intraoral approach. The incision was 2 cm in length 
and reached the buccinator muscle where the lesion was 
Fig. 1. Magnetic Resonance. Axial  plane was informed as unspecific 
pathology of the buccinator muscle.
Fig. 2. Dissection of the left side lesion.
located, and two samples of 0.5 cm of diameter were 
taken (Fig. 2).
The histopathologic examination of the removed tis-
sue described the presence of buccinator muscle fibres 
mixed with normal salivary gland acinis (choristoma of 
salivary gland), fibrosis and unspecific chronic inflam-
mation (Fig. 3).
Three months after the operation the right cheek expe-
rienced some swelling (approximately 1 cm increase in 
diameter). We explained to the patient the benign nature 
of the lesion and he decided not to have it removed.  
Discussion
The criteria for diagnosis of choristoma are a tumorlike 
growth in the soft tissues or an osseous radiolucency 
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Fig. 3. Histologic image of the removed tissue (hematoxylin and eo-
sin stain). It shows skeletal muscle with normal salivary gland acinis 
inside and unspecific chronic inflammation. Magnifications: 40X. 
Courtesy of Dr. August Vidal.
in a radiograph, histologically an ectopic tissue with a 
normal pattern, with no neoplastic features and topogra-
phically a tissue’s type not normally found in the region 
(4). SGCh has been documented in several areas of the 
organism, being the posterior lobe of pituitary gland, the 
parathyroid gland, the middle ear, the lymph nodes and 
the lower neck the most common locations. With less 
common frequency, there are case reports of the upper 
neck, the lingual mandible, the thyroid gland, the me-
diastinum, the optic nerve, the bronchus, the prostate 
gland and the rectum were published (3,6-10). This case 
report is exceptional, it isn’t any SGCh in the buccinator 
muscle, although a SGCh that affected the mandible and 
masseter muscle was described (11).
In literature, it has been reported that the age of diagno-
sis of this entity is variable, between birth to 81 years 
old (4,8,12,13). However, Haemel et al. explain that 
many lesions in this series were noted at birth or early 
in childhood and the late diagnosis were when the size 
was very small or there was an absence of symptoms 
is nonexistent (6). There is not any evidence about sex 
preference (7,12,13).
The presentation of bilateral and symmetric SGCh, just 
as our case, is very rare. However, few cases of bilateral 
choristomas in the neck have been described in literature 
(6,7).
The most frequent clinical presentation is a painless tu-
mor (7). This mass may be asymptomatic or present an 
intermittent production of a clear fluid as saliva associa-
ted with eating. Inflammatory signs can occur (1,6,7). 
The present patient presented periods of swelling of the 
cheeks associated with copious eating and but there was 
no evidence drainage. 
It must be taken into account that the clinical presenta-
tion depends of location. SGCh in the jaw, called Stafne 
bone cavity, are usually radiological findings (4,14). Ne-
vertheless, SGCh in the middle ear may cause hypoacu-
sia of conduction, disformation of the internal auditory 
canal and facial paralysis (13,15) and salivary gland 
ectopia in the rectum may manifest with rectal bleeding 
and/or tenesmus (7).
Aetiopathogenesis is unknown but it is believed to be re-
lated to embrionary development (1,2,4,5,13). In 1968, 
Willis suggested 3 general hypotheses: a) abnormal per-
sistence and development of vestigial structures; b) the 
abnormal differentiation of local tissues; and c) the dis-
location of a portion of a definitive rudimentary organ 
during its movement and development (2,8). Although, 
Hsu et al. (16) reported a case of a family with five gene-
ration suffering salivary gland heterotopias in the neck 
suggesting the existence of an autosomal dominant in-
heritance, some authors explain the choristoma’s origin 
as a type of metaplasya or development disorder where 
undifferentiated stem cells become mature salivary tis-
sue (12).
The SGCh histology shows normal salival tissue, mu-
cous and mixed acini predilection that may be accom-
panied with fibrosis and, sometimes, may difficult the 
histological diagnose. Some of the variation seen within 
the associated ducts, such as areas of squamous metapla-
sia, may be related to chronic inflammation and lymph 
infiltration secondary to physical pressure of retained 
mucus (6,7). The present case showed these histological 
features and the changes in size were probably due to 
mucosal secretion and chronic swelling. 
Tumours in SGCh are rare and 80% of them are benign 
(6,8). The most frequent benign neoplasm is Whartin’s 
tumour followed by pleomorphic adenoma. The most 
described malignant neoplasm is mucoepidermoid car-
cinoma (8). In the diagnosis of a malignant neoplasm 
of salival aberrant tissue, it is important to consider the 
possibility of it being a metastasis of a primary salivary 
gland tumour (2,6,8). 
There is much controversy in the treatment of SGCh 
because of the malignization possibility. There are two 
opinions. In one hand, some authors believe that sali-
val heterotopia is a normal tissue and doesn’t require 
complete excision when it is diagnosed histologically. 
Choristoma removal is only necessary when there are 
signs of infection or neoplasm (1,13,17). In the other 
hand, some authors prefer the complete removal of the 
mass (1,2,6,12,18). Although malignization is very rare, 
choristomas are immature in nature, which theoretically 
increase the chancy to malignization (19). 
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